Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38682569
2.
Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate.
Clin Infect Dis
; 76(3): e1350-e1359, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35639602
3.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
J Infect Dis
; 225(9): 1521-1532, 2022 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33319249
4.
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis
; 75(1): 107-117, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34606595
5.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med
; 381(21): 2009-2019, 2019 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31693803
6.
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Lancet
; 395(10234): 1434-1443, 2020 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32197107
7.
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Lancet
; 395(10234): 1423-1433, 2020 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32197105
8.
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Rev Panam Salud Publica
; 45: e67, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34131423
9.
Safety of Dengue Vaccine?
Clin Infect Dis
; 76(4): 771-772, 2023 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36196620
10.
Topological linkage disequilibrium calculated from coalescent genealogies.
Theor Popul Biol
; 124: 41-50, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30243857
11.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38245116
12.
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine
; 41(7): 1398-1407, 2023 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36681529
13.
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
PLoS Negl Trop Dis
; 17(3): e0011124, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36888687
14.
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vaccine
; 41(47): 6999-7006, 2023 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37884415
15.
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial.
Vaccine
; 38(6): 1513-1519, 2020 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31843269
16.
A common genomic code for chromatin architecture and recombination landscape.
PLoS One
; 14(3): e0213278, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30865674
17.
Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.
Lancet Infect Dis
; 18(2): 162-170, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29122463
18.
Ultra Large Gene Families: A Matter of Adaptation or Genomic Parasites?
Life (Basel)
; 6(3)2016 Aug 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27509525
19.
Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
Int J Infect Dis
; 46: 71-8, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26923083
20.
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
Rev Panam Salud Publica
; 45, jun. 2021
Artigo
Inglês
| PAHOIRIS | ID: phr-54151